Hostname: page-component-586b7cd67f-t8hqh Total loading time: 0 Render date: 2024-11-30T19:37:13.908Z Has data issue: false hasContentIssue false
  • English
  • Français

Augmentation of clozapine with paliperidone in treatment-resistant schizophrenia-A case series

Published online by Cambridge University Press:  24 June 2014

Tinggang Chang ,
Wenyu Hsu ,
Siseng Huang ,
Nanying Chiu  and
Yicheng Liao
Tinggang Chang
Affiliation:
Department of Psychiatry, Changhua Christian Hospital, Changhua, Taiwan Department of Psychiatry, Lu-Tung Branch of Changhua Christian Hospital, Changhua, Taiwan
Wenyu Hsu*
Affiliation:
Department of Psychiatry, Changhua Christian Hospital, Changhua, Taiwan Department of Psychiatry, Lu-Tung Branch of Changhua Christian Hospital, Changhua, Taiwan
Siseng Huang
Affiliation:
Department of Psychiatry, Changhua Christian Hospital, Changhua, Taiwan Department of Psychiatry, Lu-Tung Branch of Changhua Christian Hospital, Changhua, Taiwan Central Taiwan University of Science and Technology, Center of General Education, Changhua, Taiwan
Nanying Chiu
Affiliation:
Department of Psychiatry, Changhua Christian Hospital, Changhua, Taiwan Department of Psychiatry, Lu-Tung Branch of Changhua Christian Hospital, Changhua, Taiwan Department of Respiratory Care, Chang Jung Christian University, Changhua, Taiwan
Yicheng Liao
Affiliation:
Department of Psychiatry, Changhua Christian Hospital, Changhua, Taiwan Department of Psychiatry, Lu-Tung Branch of Changhua Christian Hospital, Changhua, Taiwan
*
Dr Wenyu Hsu Department of Psychiatry, Lu-Tung Branch of Changhua Christian Hospital, 888 Lu-Tung Road, LuKang Town, Changhua County, Taiwan. Tel: 886-4-7789595; Fax: 886-4-7769780; E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Comment & Critique
Information
Acta Neuropsychiatrica , Volume 23 , Issue 1 , February 2011 , pp. 51 - 53
Copyright
Copyright © Cambridge University Press 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Buckley, PF, Shendarkar, N.Treatment-refractory schizophrenia. Curr Opin Psychiatry 2005;18:165–173.CrossRefGoogle ScholarPubMed
2.Chakos, M, Lieberman, J, Hoffman, E, Bradford, D, Sheitman, B.Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials. Am J Psychiatry 2001;158:518–526.CrossRefGoogle ScholarPubMed
3.Lehman, AF, Lieberman, JA, Dixon, LB et al. Practice guideline for the treatment of patients with schizophrenia, second edition. Am J Psychiatry 2004;161:1–56.Google Scholar
4National Institute for Health and Clinical Excellence. Schizophrenia core interventions in the treatment and management of schizophrenia in primary and secondary care (Update). London: NICE, 2009.Google Scholar
5.Hsu, WY, Lee, CI, Chiu, NY, Kahn, DA.Aripiprazole in treatment-refractory schizophrenia. J Psychiatr Pract 2009;15:221–226.CrossRefGoogle ScholarPubMed
6.Cipriani, A, Boso, M, Barbui, C.Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia. Cochrane Database Syst Rev 2009:CD006324.CrossRefGoogle ScholarPubMed
7.Josiassen, RC, Joseph, A, Kohegyi, E et al. Clozapine augmented with risperidone in the treatment of schizophrenia: a randomized, double-blind, placebo-controlled trial. Am J Psychiatry 2005;162:130–136.CrossRefGoogle ScholarPubMed
8.Kane, J, Canas, F, Kramer, M et al. Treatment of schizophrenia with paliperidone extended-release tablets: a 6-week placebo-controlled trial. Schizophr Res 2007;90:147–161.CrossRefGoogle ScholarPubMed
9.Canuso, CM, Youssef, EA, Bossie, CA, Turkoz, I, Schreiner, A, Simpson, GM.Paliperidone extended-release tablets in schizophrenia patients previously treated with risperidone. Int Clin Psychopharmacol 2008;23:209–215.CrossRefGoogle ScholarPubMed
10.Meltzer, HY, Bobo, WV, Nuamah, IF et al. Efficacy and tolerability of oral paliperidone extended-release tablets in the treatment of acute schizophrenia: pooled data from three 6-week, placebo-controlled studies. J Clin Psychiatry 2008; 69:817–829.CrossRefGoogle ScholarPubMed
11.Kramer, M, Simpson, G, Maciulis, V et al. Paliperidone extended-release tablets for prevention of symptom recurrence in patients with schizophrenia: a randomized, double-blind, placebo-controlled study. J Clin Psychopharmacol 2007;27:6–14.CrossRefGoogle ScholarPubMed
12.Pandurangi, AK, Dalkilic, A.Polypharmacy with second-generation antipsychotics: a review of evidence. J Psychiatr Pract 2008;14:345–367.CrossRefGoogle ScholarPubMed
13.Goodwin, G, Fleischhacker, W, Arango, C et al. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice. Eur Neuropsychopharmacol 2009;19:520–532.CrossRefGoogle ScholarPubMed
14.Hough, D, Nuamah, IF, Lim, P, Sampson, A, Gagnon, DD, Rothman, M.Independent effect of paliperidone extended release on social functioning beyond its effect on positive and negative symptoms of schizophrenia: a mediation analysis. J Clin Psychopharmacol 2009;29:496–497.CrossRefGoogle ScholarPubMed
15.Conley, R, Gupta, SK, Sathyan, G.Clinical spectrum of the osmotic-controlled release oral delivery system (OROS), an advanced oral delivery form. Curr Med Res Opin 2006;22:1879–1892.CrossRefGoogle Scholar
16.Janicak, PG, Winans, EA.Paliperidone ER: a review of the clinical trial data. Neuropsychiatr Dis Treat 2007;3:869–897.CrossRefGoogle Scholar
17.Nussbaum, A, Stroup, TS.Paliperidone for schizophrenia. Cochrane Database Syst Rev 2008:CD006369.CrossRefGoogle ScholarPubMed